The World Health Organization (WHO) congratulates Guinea for eliminating the gambiense form of human African trypanosomiasis as a public health problem. This form of human African trypanosomiasis, the ...
Chad has eliminated human African trypanosomiasis, a fly-borne tropical disease also known as sleeping sickness, the World Health Organization recently announced. The elimination marks a milestone for ...
Background. Human African trypanosomiasis (HAT) caused by Trypanosoma brucei gambiense can be diagnosed in the early hemolymphatic stage (stage 1 [S1]) or meningoencephalitic stage (stage 2 [S2]).
A multi-center, open-level, phase II/III clinical trial has recently been conducted to evaluate the efficacy and safety of the oral antimicrobial drug acoziborole in patients with human African ...
A single dose of oral acoziborole proved to be efficacious and safe for adults and adolescents with gambiense human African trypanosomiasis (HAT), also known as "sleeping sickness," suggesting its ...
Scientists have discovered a new class of compound that is potentially active against trypanosome parasites that cause human African trypanosomiasis (or sleeping sickness) and Chagas disease. The ...
The African Union (AU) and Kenya have urged African countries to deploy Artificial Intelligence (AI) in the management of trypanosomiasis. Dr. Huyam Salih, Director of the African Union InterAfrican ...
African trypanosomiasis (also known as sleeping sickness) is a disease transmitted by tsetse flies and is fatal to humans and other animals; however, there is currently no vaccine, this disease is ...
A single dose of oral acoziborole resulted in a greater than 95% cure or probable cure rate for human African trypanosomiasis (HAT), also known as sleeping sickness, according to results from a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback